LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - KalVista Pharmaceuticals (NASDAQ: KALV)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KALV KalVista Pharmaceuticals
Palleiko Benjamin L / director, officer: CHIEF EXECUTIVE OFFICER
12/09/2024
Sell
$9.75
7,627
$74K
274,596
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
11/26/2024
Sell
$9.87
2,187
$22K
97,012
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
11/26/2024
Sell
$9.87
1,963
$19K
91,142
NASDAQ KALV KalVista Pharmaceuticals
Reid Laurence / director
11/23/2024
Buy
$10.07
17,000
$171K
17,000
NASDAQ KALV KalVista Pharmaceuticals
Palleiko Benjamin L / director, officer: CHIEF EXECUTIVE OFFICER
11/18/2024
Sell
$9.26
14,400
$133K
266,598
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
11/18/2024
Sell
$9.26
7,192
$67K
89,980
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
11/18/2024
Sell
$9.26
8,077
$75K
94,199

COPYRIGHT ©2023 HEALTH STOCKS HUB